Historique
Brochure
Policy brief: Antiretroviral therapy and injecting drug users
Titre de série :
Evidence for action on HIV/AIDS and injecting drug use
Auteur(s) :
OMS / WHO (Organisation mondiale de la santé / World Health Organization) ;
UNAIDS = ONUSIDA (Joint United Nations Programme on HIV/AIDS) ;
UNODCCP (United Nations Office for Drug Control and Crime Prevention / Office des Nations Unies pour le contrôle des drogues et la prévention du crime)
Année
2005
Page(s) :
7 p.
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Anglais
Éditeur(s) :
Genève : OMS / WHO
Collection :
Evidence for action policy brief, WHO/HIV/2005.06
Refs biblio. :
43
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
ANTIRETROVIRAUX
;
VIH
;
USAGER
;
INJECTION
;
PROGRAMME
;
TRAITEMENT
;
EVALUATION
;
EFFICACITE
Résumé :
This policy brief reviews the evidence to date on providing antiretroviral (ARV) therapy to HIV-positive injecting drug users. A number of related medical, psychological and social issues are also addressed including the need to manage drug interactions and the benefit of harm reduction interventions in supporting optimum care for HIV-positive injecting drug users. General issues related to HIV care are examined in WHO (2003) 'Scaling up Antiretroviral Therapy in Resource Limited Settings'; while other 'Evidence for Action Policy Briefs' provide more detailed information on harm reduction. The WHO/UNODC/UNAIDS position paper on substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention provides a concise summary of the UN position regarding opioid substitution therapy.
Affiliation :
Switzerland
Autre(s) lien(s) :
Scaling up Antiretroviral Therapy in Resource Limited Settings